Bangayan, Hilda T.
HRN: 21-81-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2022
CEFUROXIME 500MG (TAB)
08/14/2022
08/14/2022
ORAL
500mg
BID
NSVD ER Delivery- W/ 1st Degree Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes